MarketInOut Stock Screener Log In | Sign Up

Drugs Made In America Acquisition Corp Rt

NASDAQ • Financial Services • Shell Companies • Quote as of 10/28/2026 16:00
Drugs Made In America Acquisition Corp Rt stock price and volume chart

Company Profile

IndustryShell Companies
SectorFinancial Services
ExchangeNASDAQ
Market Capitalization289.62 mln
Float19.79 mln
Earnings Date05/20/2025

EPS

0.20
Marginal

P / E

0.48
Anomalous

Relative Strength

7 / 100
Severely lagging

Debt / Equity

0.01
Debt-free

ROE

2.92
Very low

ROA

4.15
Moderate

Business Description

Founded in 2024 and headquartered in Fort Lauderdale, Florida, Drugs Made In America Acquisition Corp. is a shell company set up to find and complete a deal with an existing business. The company is open to various deal structures, including mergers, asset purchases, or other arrangements that would bring an operating business under its umbrella.

Key Fundamentals

EPS0.20
P/E0.48
ROE2.92
ROIC-1.82
ROA4.15
EBITDA, mln-2.63
EV / EBITDA-101

Quote Details

Last 0.0955
Change -0.0139 (-12.71%)
Open 0.0955
Volume 103
Turnover 9.84
Average Volume 10,950

Financial Ratios

Leverage Ratio1.07
Current Ratio0.02
Price / Book1.59
Debt / Equity0.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -19.07% 3 / 100   
1 Month -24.45% 12 / 100   
2 Months -12.55% 27 / 100   
6 Months 59.17% 96 / 100   
1 Year -43.82% 20 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog